NOAEL Studies
Cosmetic Ingredient
Dihydroxyindoline NOAEL Studies
INCI: DIHYDROXYINDOLINE
CAS: 29539-03-5
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 20 | mg/kg bw/day | rat | oral | 13 week | Subchronic | SCCNFP; Pharmakon Europe, France. Study No 328/512; Henkel KGaA Report No 9501030 (1995) |
| COSMOS DB | NOAEL | 10 | mg/kg bw/day | rat | oral | 13 week | Subchronic | SCCNFP; Pharmakon Europe, France. Study No 328/512; Henkel KGaA Report No 9501030 (1995) |
SCCNFP Opinion 7 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCNFP Opinion | NOAEL | =2 | % | rat | oral | subchronic | repeated dose toxicity | p.18 |
| SCCNFP Opinion | NOAEL | =10 | mg/kg/day | rat | dermal | Sub-chronic | repeated dose toxicity | Ref. : 19 2, p.9 |
| SCCNFP Opinion | NOAEL | =10 | mg/kg | rat | oral | 90 day | dermal absorption | p.18 |
| SCCNFP Opinion | NOAEL | =10 | mg/kg bw/day | rat | oral | subchronic | repeated dose toxicity | p.18 |
| SCCNFP Opinion | NOAEL | =20 | mg/kg bw/day | rat | - | - | NOAEL study | Ref. : 13, p.7 |
| SCCNFP Opinion | NOAEL | =180 | mg/kg bw/day | rat | - | 4 weeks | NOAEL study | p.7 |
| SCCNFP Opinion | NOAEL | =240 | mg/kg bw/day | rat | dermal | - | dermal absorption | Ref. : 15, 16 2, p.13 |
Regulatory source 7 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 20 | mg/kg bw/day | rat | - | - | - | p.7 |
| Regulatory source | - | 180 | mg/kg bw/day | rat | - | 4 weeks | - | p.7 |
| Regulatory source | dermal absorption | =10 | mg/kg | rat | oral | 90 day | dermal absorption | p.18 |
| Regulatory source | dermal absorption | 240 | mg/kg bw/day | rat | dermal | - | dermal absorption | p.13 |
| Regulatory source | repeated dose toxicity | 2 | % | rat | oral | subchronic | repeated dose toxicity | p.18 |
| Regulatory source | repeated dose toxicity | 10 | mg/kg/day | rat | dermal | Sub-chronic | repeated dose toxicity | p.9 |
| Regulatory source | repeated dose toxicity | 10 | mg/kg bw/day | rat | oral | subchronic | repeated dose toxicity | p.18 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | HH49N58FJ9 | UNII | - | - | - | chemical | - |